Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000150716 | SCV000168649 | benign | not specified | 2014-03-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000150716 | SCV000198134 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Gly254Gly in Exon 05 of GATAD1: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence and has been identified in 0.3% (24/7020) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs139637606). |
Eurofins Ntd Llc |
RCV000150716 | SCV000231165 | likely benign | not specified | 2014-10-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000233449 | SCV000290584 | benign | Dilated cardiomyopathy 2B | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620934 | SCV000735928 | benign | Cardiovascular phenotype | 2017-07-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000233449 | SCV000743185 | benign | Dilated cardiomyopathy 2B | 2014-10-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000858023 | SCV001155134 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | GATAD1: BP4, BP7 |
ARUP Laboratories, |
RCV000233449 | SCV002049254 | likely benign | Dilated cardiomyopathy 2B | 2021-03-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000233449 | SCV002807112 | benign | Dilated cardiomyopathy 2B | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000233449 | SCV000734586 | likely benign | Dilated cardiomyopathy 2B | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000858023 | SCV001972823 | likely benign | not provided | no assertion criteria provided | clinical testing |